BIOTECH ACQUISITION COMPANY - Key Persons


Aaron Kim

Job Titles:
  • Director
Co-founder and Managing Partner of Valparaiso Capital Partners, an Asia-focused private equity firm regionally based in Singapore, which invests in businesses and assets that provide institutional investors with specific participation on a direct investment and non-discretionary basis Valparaiso co-invests, acts as the sponsor of and represents principal investors for each of its projects With Board level representation, larger investors have included sovereign wealth funds, public and private university endowments, insurance companies, private equity funds, and multi-family offices Aaron has been involved in private equity principal investing since 1995 in Asia, leveraging his experience in technology, investment banking, and real estate development, including BSL-2 biology and chemistry laboratory facilities

Albert Hummel

Job Titles:
  • Senior Partner of SPRIM
Over 40 years of diverse business and capital markets experience with a history of recognizing valuable business opportunities early on and capitalizing on their intrinsic value, especially in the healthcare market

Bruno Montanari

With a background in venture capital and investment banking focused in the pharmaceutical, biotechnology and medical device industries, Bruno brings a wealth of international experience and network in emerging life sciences to Biotech Acquisition Company We believe he is well qualified to serve as a Member of our Board due to his extensive industry, investment research, financial market and related experience

Dr. Michael Shleifer - CEO, Founder

Job Titles:
  • Co - Founder
  • Founder
  • Managing Partner
  • CRO Services
Co-founder and Managing Partner of SPRIM, a consulting and CRO services firm employing 500 people across 17 countries Founder of SPRIM Ventures, an investment firm focused in biotech and digital health solutions, with portfolio company aggregate valuations of over $200mm

Ivan Jarry

Job Titles:
  • Co - Founder and Managing Partner of SPRIM / Chief Executive Officer of ObvioHealth
Ivan has created and grown over 40 companies in the health innovation space, including consulting practices, to CROs, ​and ventures focused in digital health and biotech His expertise lies in seeding and structuring businesses for rapid growth through platform and process scalability, data integration and effective leadership, which has translated to significant growth in both revenue (up to 7 times year-over-year) and valuation (more than $200 million over the past 2 years) for the ventures under his leadership He has lived and worked in 8 countries and is fluent in 4 languages Education: Masters, EDHEC Business School in France

Merill Lynch

Job Titles:
  • Analyst
Education: Lycee Montaigne ESCP Business School

Paul Bernard

Job Titles:
  • Non - Executive Director of Conrad Petroleum, Castle European, Sandbox Entertainment Holdings
Paul has lived and worked in Asia for 26 years He is a CFA charterholder We believe he is well qualified to serve as a Member of our Board due to his extensive industry, investment research, financial market and related experience

Tanguy Serra - Chief Investment Officer, Founder, President

Job Titles:
  • Asset Manager
  • Chief Investment Officer
  • Co - Founder
  • President
Tanguy has extensive experience across capital markets, clean energy, and financial technology

Thomas Fratacci - CFO, Treasurer

Job Titles:
  • Chief Financial Officer
  • Treasurer
Group CFO of SPRIM and SPRIM Ventures, responsible for all finance functions within the Group and for developing robust business models to support financing rounds and exits Thomas participated in the early years of SPRIM's development, both in Asia and the US He has 20 years of experience in corporate finance and business management in B2B environments Prior positions: Thomas started his career in financial audit and advisory services, first with Arthur Andersen and then with KPMG